AAAAAA

   
Results: 1-17 |
Results: 17
Phase II evaluation of suramin in advanced renal cell carcinoma - A Southwest Oncology Group study
Authors: Schroder, LE Lew, D Flanigan, RC Eisenberger, MA Seay, TE Hammond, N Needles, BM Crawford, ED
Citation: Le. Schroder et al., Phase II evaluation of suramin in advanced renal cell carcinoma - A Southwest Oncology Group study, UROL ONCOL, 6(4), 2001, pp. 145-148
A phase I clinical and pharmacological evaluation of sodium phenylbutyrateon an 120-h infusion schedule
Authors: Carducci, MA Gilbert, J Bowling, MK Noe, D Eisenberger, MA Sinibaldi, V Zabelina, Y Chen, TL Grochow, LB Donehower, RC
Citation: Ma. Carducci et al., A phase I clinical and pharmacological evaluation of sodium phenylbutyrateon an 120-h infusion schedule, CLIN CANC R, 7(10), 2001, pp. 3047-3055
Recent developments in chemotherapy for bladder cancer - The Vaughn/Malkowicz article reviewed
Authors: Eisenberger, MA
Citation: Ma. Eisenberger, Recent developments in chemotherapy for bladder cancer - The Vaughn/Malkowicz article reviewed, ONCOLOGY-NY, 15(6), 2001, pp. 779-780
Prostate cancer - Preface
Authors: Carducci, MA Eisenberger, MA
Citation: Ma. Carducci et Ma. Eisenberger, Prostate cancer - Preface, HEMAT ONCOL, 15(3), 2001, pp. XI-XII
A phase II trial of estramustine and etoposide in hormone refractory prostate cancer: A Southwest Oncology GroupTrial (SWOG 9407)
Authors: Pienta, KJ Fisher, EI Eisenberger, MA Mills, GM Goodwin, JW Jones, JA Dakhil, SR Crawford, ED Hussain, MHA
Citation: Kj. Pienta et al., A phase II trial of estramustine and etoposide in hormone refractory prostate cancer: A Southwest Oncology GroupTrial (SWOG 9407), PROSTATE, 46(4), 2001, pp. 257-261
Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: A Southwest Oncology Group Study (SWOG 9235)
Authors: Kucuk, O Fisher, E Moinpour, CM Coleman, D Hussain, MHA Sartor, AO Chatta, GS Lowe, BA Eisenberger, MA Crawford, ED
Citation: O. Kucuk et al., Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: A Southwest Oncology Group Study (SWOG 9235), UROLOGY, 58(1), 2001, pp. 53-58
Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy
Authors: Roberts, WW Bergstralh, EJ Blute, ML Slezak, JM Carducci, M Han, M Epstein, JI Eisenberger, MA Walsh, PC Partin, AW
Citation: Ww. Roberts et al., Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy, UROLOGY, 57(6), 2001, pp. 1033-1037
A structured debate: Immediate versus deferred androgen suppression in prostate cancer - Evidence for deferred treatment
Authors: Walsh, PC DeWeese, TL Eisenberger, MA
Citation: Pc. Walsh et al., A structured debate: Immediate versus deferred androgen suppression in prostate cancer - Evidence for deferred treatment, J UROL, 166(2), 2001, pp. 508-515
NCCN Practice Guidelines for cancer-related fatigue
Authors: Mock, V Atkinson, A Barsevick, A Cella, D Cimprich, B Cleeland, C Donnelly, J Eisenberger, MA Escalante, C Hinds, P Jacobsen, PB Kaldor, P Knight, SJ Peterman, A Piper, BF Rugo, H Sabbatini, P Stahl, C
Citation: V. Mock et al., NCCN Practice Guidelines for cancer-related fatigue, ONCOLOGY-NY, 14(11A), 2000, pp. 151-161
Androgen deprivation and four courses of fixed-schedule suramin treatment in patients with newly diagnosed metastatic prostate cancer: A southwest oncology group study
Authors: Hussain, M Fisher, EI Petrylak, DP O'Connor, J Wood, DP Small, EJ Eisenberger, MA Crawford, ED
Citation: M. Hussain et al., Androgen deprivation and four courses of fixed-schedule suramin treatment in patients with newly diagnosed metastatic prostate cancer: A southwest oncology group study, J CL ONCOL, 18(5), 2000, pp. 1043-1049
Management of patients with rising prostate-specific antigen after radicalprostatectomy
Authors: Laufer, M Pound, CR Carducci, MA Eisenberger, MA
Citation: M. Laufer et al., Management of patients with rising prostate-specific antigen after radicalprostatectomy, UROLOGY, 55(3), 2000, pp. 309-315
Does prolonged combined androgen blockade have survival benefits over short-term combined androgen blockade therapy? Editorial Comment
Authors: Eisenberger, MA
Citation: Ma. Eisenberger, Does prolonged combined androgen blockade have survival benefits over short-term combined androgen blockade therapy? Editorial Comment, UROLOGY, 55(3), 2000, pp. 395-396
Complete androgen blockade for prostate cancer: What went wrong?
Authors: Laufer, M Denmeade, SR Sinibaldi, VJ Carducci, MA Eisenberger, MA
Citation: M. Laufer et al., Complete androgen blockade for prostate cancer: What went wrong?, J UROL, 164(1), 2000, pp. 3-9
Identification and characterization of circulating prostate carcinoma cells
Authors: Wang, ZP Eisenberger, MA Carducci, MA Partin, AW Scher, HI Ts'o, POP
Citation: Zp. Wang et al., Identification and characterization of circulating prostate carcinoma cells, CANCER, 88(12), 2000, pp. 2787-2795
Natural history of progression after PSA elevation following radical prostatectomy
Authors: Pound, CR Partin, AW Eisenberger, MA Chan, DW Pearson, JD Walsh, PC
Citation: Cr. Pound et al., Natural history of progression after PSA elevation following radical prostatectomy, J AM MED A, 281(17), 1999, pp. 1591-1597
Incidental non-Hodgkin's lymphoma in patients with localized prostate cancer
Authors: Eisenberger, CF Walsh, PC Eisenberger, MA Chow, NH Martin, AW Mostwin, JL Marshall, FF Epstein, JI Schoenberg, M
Citation: Cf. Eisenberger et al., Incidental non-Hodgkin's lymphoma in patients with localized prostate cancer, UROLOGY, 53(1), 1999, pp. 175-179
Early androgen deprivation for prostate cancer?
Authors: Eisenberger, MA Walsh, PC
Citation: Ma. Eisenberger et Pc. Walsh, Early androgen deprivation for prostate cancer?, N ENG J MED, 341(24), 1999, pp. 1837-1838
Risultati: 1-17 |